```

Exhibit 31.1
Certification Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002

      CERTIFICATION ACCOMPANYING PERIODIC REPORT PURSUANT TO SECTION 302 OF
                         THE SARBANES-OXLEY ACT OF 2002

I, Lam Ko Chau, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Liska Biometry,
     Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect  to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     Liska Biometry, Inc. as of, and for, the periods presented in this report;

4.   The small business issuer's other certifying officer(s) and I are
     responsible for establishing and maintaining disclosure controls and
     procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
     internal control over financial reporting (as defined in Exchange Act Rules
     13a-15(f) and 15d-15(f)) for Liska Biometry, Inc.and have:

     a.   Designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designed under our
          supervision, to ensure that material information relating to Liska
          Biometry, Inc., including its consolidated subsidiaries, is made known
          to us by others within those entities, particularly during the period
          in which this report is being prepared;

     b.   Designed such internal control over financial reporting, or caused
          such internal control over financial reporting to be designed under
          our supervision, to provide reasonable assurance regarding the
          reliability of financial reporting and the preparation of financial
          statements for external purposes in accordance with generally accepted
          accounting principles;

     c.   Evaluated the effectiveness of Liska Biometry, Inc.'s disclosure
          controls and procedures and presented in this report our conclusions
          about the effectiveness of the disclosure controls and procedures, as
          of the end of the period covered by this report based on such
          evaluation; and

     d.   Disclosed in this report any change in Liska Biometry, Inc.'s internal
          control over financial reporting that occurred during the small
          business issuer's most recent fiscal quarter (the small business
          issuer's fourth fiscal quarter in the case of an annual report) that
          has materially affected, or is reasonably likely to materially affect,
          Liska Biometry, Inc.'s internal control over financial reporting; and

5.   The small business issuer's other certifying officer(s) and I have
     disclosed, based on our most recent evaluation of internal control over
     financial reporting, to Liska Biometry, Inc.'s auditors and the audit
     committee of Liska Biometry, Inc.'s board of directors (or persons
     performing the equivalent functions):

     a.   All significant deficiencies and material weaknesses in the design or
          operation of internal control over financial reporting which are
          reasonably likely to adversely affect Liska Biometry, Inc.'s ability
          to record, process, summarize and report financial information; and

     b.   Any fraud, whether or not material, that involves management or other
          employees who have a significant role in Liska Biometry, Inc.'s
          internal control over financial reporting.

/s/ Lam Ko Chau
Lam Ko Chau, President (Principal Executive Officer), Chief Financial Officer
and Principal Accounting Officer

November 12, 2003
```